mrr pvt. Ltd.

United States Biosimilar Drug Market Report 2017

Press Release   •   Feb 01, 2017 15:57 IST

p { margin-bottom: 0.25cm; line-height: 120%; }a:link { }

This report studies sales (consumption) of Biosimilar Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

CP Guojian Pharma

Biotech Pharma

Celgen Pharma


Market Segment by States, covering



New York



Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into




Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into

Ankylosing Spondylitis


Rheumatoid Arthrtis


Table of Contents

United States Biosimilar Drug Market Report 2017

1 Biosimilar Drug Overview

1.1 Product Overview and Scope of Biosimilar Drug

1.2 Classification of Biosimilar Drug

1.2.1 Injection

1.2.2 Tablets

1.2.3 Others

1.3 Application of Biosimilar Drug

1.3.1 Ankylosing Spondylitis

1.3.2 Tumor

1.3.3 Rheumatoid Arthrtis

1.3.4 Cardiovascular

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biosimilar Drug (2012-2022)

1.4.1 United States Biosimilar Drug Sales and Growth Rate (2012-2022)

1.4.2 United States Biosimilar Drug Revenue and Growth Rate (2012-2022)

Download Sample Copy of This Report at: